These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6701753)
1. An experimental study of the influence of antifibrinolytic therapy on post-subarachnoid-hemorrhagic cerebral vasospasm and hydrocephalus. Kenning JA; Heros RC; Dujovny M; Latchaw RE; Nelson D Surg Neurol; 1984 Feb; 21(2):159-64. PubMed ID: 6701753 [TBL] [Abstract][Full Text] [Related]
2. Medical management of patients following a ruptured cerebral aneurysm, with epsilon-aminocaproic acid, kanamycin, and reserpine. Knuckey NW; Stokes BA Surg Neurol; 1982 Mar; 17(3):181-5. PubMed ID: 7079936 [TBL] [Abstract][Full Text] [Related]
3. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial. Shucart WA; Hussain SK; Cooper PR J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206 [TBL] [Abstract][Full Text] [Related]
4. Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage. Adams HP Stroke; 1982; 13(2):256-9. PubMed ID: 7039006 [No Abstract] [Full Text] [Related]
5. Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage. Nibbelink DW; Torner JC; Henderson WG Stroke; 1975; 6(6):622-9. PubMed ID: 1198627 [TBL] [Abstract][Full Text] [Related]
6. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm. Ramirez-Lassepas M Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208 [TBL] [Abstract][Full Text] [Related]
7. Spontaneous subarachnoid hemorrhage complicated by communicating hydrocephalus: epsilon amino caproic acid as a possible predisposing factor. Park BE Surg Neurol; 1979 Jan; 11(1):73-80. PubMed ID: 451853 [TBL] [Abstract][Full Text] [Related]
8. Hydrocephalus and vasospasm after subarachnoid hemorrhage from ruptured intracranial aneurysms. Black PM Neurosurgery; 1986 Jan; 18(1):12-6. PubMed ID: 3945373 [TBL] [Abstract][Full Text] [Related]
9. Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm. Solomon RA; Post KD; McMurtry JG Neurosurgery; 1984 Sep; 15(3):354-61. PubMed ID: 6483150 [TBL] [Abstract][Full Text] [Related]
10. Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy. Leipzig TJ; Redelman K; Horner TG J Neurosurg; 1997 Feb; 86(2):220-5. PubMed ID: 9010423 [TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytics in aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy. Spallone A Acta Neurochir (Wien); 1982; 63(1-4):245-50. PubMed ID: 6179402 [TBL] [Abstract][Full Text] [Related]
12. Antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage increases the risk for deep venous thrombosis: A case-control study. Foreman PM; Chua M; Harrigan MR; Fisher WS; Tubbs RS; Shoja MM; Griessenauer CJ Clin Neurol Neurosurg; 2015 Dec; 139():66-9. PubMed ID: 26378393 [TBL] [Abstract][Full Text] [Related]
13. epsilon-aminocaproic acid in prevention of subarachnoid haemorrhage. Wintzen AR; Van Rossum J Lancet; 1979 May; 1(8125):1084. PubMed ID: 86803 [No Abstract] [Full Text] [Related]
14. Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus. Harrigan MR; Rajneesh KF; Ardelt AA; Fisher WS Neurosurgery; 2010 Oct; 67(4):935-9; discussion 939-40. PubMed ID: 20881558 [TBL] [Abstract][Full Text] [Related]